Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Moodys
Chubb
US Department of Justice
Cantor Fitzgerald
Colorcon
Healthtrust
Johnson and Johnson
Cerilliant
Farmers Insurance

Generated: February 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 050278

« Back to Dashboard

NDA 050278 describes ACHROMYCIN V, which is a drug marketed by Heritage Pharma and Lederle and is included in two NDAs. It is available from two suppliers. Additional details are available on the ACHROMYCIN V profile page.

The generic ingredient in ACHROMYCIN V is tetracycline hydrochloride. There are ninety-nine drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the tetracycline hydrochloride profile page.
Summary for 050278
Tradename:ACHROMYCIN V
Applicant:Heritage Pharma
Ingredient:tetracycline hydrochloride
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Pharmacology for NDA: 050278
Ingredient-typeTetracyclines
Suppliers and Packaging for NDA: 050278
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ACHROMYCIN V tetracycline hydrochloride CAPSULE;ORAL 050278 NDA Heritage Pharmaceuticals Inc. 23155-017 N 23155-017-01
ACHROMYCIN V tetracycline hydrochloride CAPSULE;ORAL 050278 NDA Heritage Pharmaceuticals Inc. 23155-017 N 23155-017-10

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength500MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength250MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Daiichi Sankyo
Cipla
Mallinckrodt
Chinese Patent Office
Deloitte
Federal Trade Commission
Fuji
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot